This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matoskova, B. Articles by Di Fiore, P. P. Search for Related Content PubMed PubMed Citation Articles by Matoskova, B. Articles by Di Fiore, P. P.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jul 1995, 3805-3812, Vol 15, No. 7

Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation

B Matoskova, WT Wong, AE Salcini, PG Pelicci and PP Di Fiore
Laboratory of Cellular Development and Oncology, National Institute of Dental Research, National Cancer Institute, Bethesda, Maryland 20892, USA.

eps8, a recently identified tyrosine kinase substrate, has been shown to augment epidermal growth factor (EGF) responsiveness, implicating it in EGF receptor (EGFR)-mediated mitogenic signaling. We investigated the status of eps8 phosphorylation in normal and transformed cells and the role of eps8 in transformation. In NIH 3T3 cells overexpressing EGFR (NIH-EGFR), eps8 becomes rapidly phosphorylated upon EGF stimulation. At receptor-saturating doses of EGF, approximately 30% of the eps8 pool is tyrosine phosphorylated. Under physiological conditions of activation (i.e., at low receptor occupancy), corresponding to the 50% effective dose of EGF for mitogenesis, approximately 3 to 4% of the eps8 contains phosphotyrosine. In human tumor cell lines, we detected constitutive tyrosine phosphorylation of eps8, with a stoichiometry (approximately 5%) similar to that associated with potent mitogenic response in NIH-EGFR cells. Overexpression of eps8 was able to transform NIH 3T3 cells under limiting conditions of activation of the EGFR pathway. Concomitant tyrosine phosphorylation of eps8 and shc, but not of rasGAP, phospholipase C-gamma, and eps15, was frequently detected in tumor cells. This suggested that eps8 and shc might be part of a pathway which is preferentially selected in some tumors. Cooperation between these two transducers was further indicated by the finding of their in vivo association. This association was, at least in part, dependent on recognition of shc by the SH3 domain of eps8. Our results indicate that eps8 is physiologically part of the EGFR-activated signaling and that its alterations can contribute to the malignant phenotype.

This article has been cited by other articles:

• Xu, M., Shorts-Cary, L., Knox, A. J., Kleinsmidt-DeMasters, B, Lillehei, K., Wierman, M. E. (2009). Epidermal Growth Factor Receptor Pathway Substrate 8 Is Overexpressed in Human Pituitary Tumors: Role in Proliferation and Survival. Endocrinology 150: 2064-2071 [Abstract] [Full Text]  
• Wang, H., Patel, V., Miyazaki, H., Gutkind, J.S., Yeudall, W.A. (2009). Role for EPS8 in squamous carcinogenesis. Carcinogenesis 30: 165-174 [Abstract] [Full Text]  
• Yao, J., Weremowicz, S., Feng, B., Gentleman, R. C., Marks, J. R., Gelman, R., Brennan, C., Polyak, K. (2006). Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.. Cancer Res. 66: 4065-4078 [Abstract] [Full Text]  
• Funato, Y., Terabayashi, T., Suenaga, N., Seiki, M., Takenawa, T., Miki, H. (2004). IRSp53/Eps8 Complex Is Important for Positive Regulation of Rac and Cancer Cell Motility/Invasiveness. Cancer Res. 64: 5237-5244 [Abstract] [Full Text]  
• Leu, T.-H., Yeh, H. H., Huang, C.-C., Chuang, Y.-C., Su, S. L., Maa, M.-C. (2004). Participation of p97Eps8 in Src-mediated Transformation. J. Biol. Chem. 279: 9875-9881 [Abstract] [Full Text]  
• Davol, P. A., Bagdasaryan, R., Elfenbein, G. J., Maizel, A. L., Frackelton, A. R. Jr. (2003). Shc Proteins Are Strong, Independent Prognostic Markers for Both Node-Negative and Node-Positive Primary Breast Cancer. Cancer Res. 63: 6772-6783 [Abstract] [Full Text]  
• Lai, K.-M. V., Pawson, T. (2000). The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. Genes Dev. 14: 1132-1145 [Abstract] [Full Text]  
• Cozzolino, M, Giovannone, B, Serafino, A, Knudsen, K, Levi, A, Alema, S, Salvatore, A (2000). Activation of TrkA tyrosine kinase in embryonal carcinoma cells promotes cell compaction, independently of tyrosine phosphorylation of catenins. J. Cell Sci. 113: 1601-1610 [Abstract]  
• Tassi, E., Biesova, Z., Di Fiore, P. P., Gutkind, J. S., Wong, W. T. (1999). Human JIK, a Novel Member of the STE20 Kinase Family That Inhibits JNK and Is Negatively Regulated by Epidermal Growth Factor. J. Biol. Chem. 274: 33287-33295 [Abstract] [Full Text]  
• Zou, X., Calame, K. (1999). Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase. J. Biol. Chem. 274: 18141-18144 [Full Text]  
• O'Bryan, J. P., Lambert, Q. T., Der, C. J. (1998). The Src Homology 2 and Phosphotyrosine Binding Domains of the ShcC Adaptor Protein Function as Inhibitors of Mitogenic Signaling by the Epidermal Growth Factor Receptor. J. Biol. Chem. 273: 20431-20437 [Abstract] [Full Text]  
• Coda, L., Salcini, A. E., Confalonieri, S., Pelicci, G., Sorkina, T., Sorkin, A., Pelicci, P. G., Di Fiore, P. P. (1998). Eps15R Is a Tyrosine Kinase Substrate with Characteristics of a Docking Protein Possibly Involved in Coated Pits-mediated Internalization. J. Biol. Chem. 273: 3003-3012 [Abstract] [Full Text]  
• Thomas, D., Bradshaw, R. A. (1997). Differential Utilization of ShcA Tyrosine Residues and Functional Domains in the Transduction of Epidermal Growth Factor-induced Mitogen-activated Protein Kinase Activation in 293T Cells and Nerve Growth Factor-induced Neurite Outgrowth in PC12 Cells. IDENTIFICATION OF A NEW Grb2·Sos1 BINDING SITE. J. Biol. Chem. 272: 22293-22299 [Abstract] [Full Text]